|20.67|| +0.01 / +0.05%|
Fresenius SE & Co. KGaA is a global healthcare group, which engages in the provision of products, and services for dialysis, hospitals, and outpatient medical care. It operates through the following business segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, Fresenius Vamed, and Corporate & Other. The Fresenius Medical Care segment is comprised of dialysis products, and healthcare services. The Fresenius Kabi segment provides intravenous drugs, clinical nutrition, infusion therapy, medical devices, and transfusion technology. The Fresenius Helios is the hospital operations. The Fresenius Vamed is consist of projects, and services for hospitals and other healthcare facilities. The Corporate & Other segment engages in the holding activities. The company was founded by Eduard Fresenius in October 1912 and is headquartered in Bad Homburg, Germany.
|Stephan Sturm||President & Chief Executive Officer|
|Rachel Clare Empey||Chief Financial Officer & Member-Management Board|
|Jürgen Götz||Chief Legal, Compliance & Human Resources Officer|
|Rice Powell||Chief Executive Officer-Fresenius Medical Care|
|Mats Christer Henriksson||CEO-Fresenius Kabi & Member-Management Board|